Antibiotic prescriptions in Lombardy Region according to WHO AWaRe classification: trend from 2000 to 2024 Authors: Chiara Elli, Chiara Crippa, Ida Fortino, Alessandro Nobili, Luca Pasina Published: 2026 ABSTRACT AbstractAntimicrobial resistance represents a significant threat to public health. The aim of the study was to examine trends in antibiotic prescription in Lombardy and to assess the prevalence and patterns according to the WHO AWaRe classification. This retrospective cohort study was based on healthcare utilization databases from the Lombardy Region, Italy. Residents between 2000 and 2024 who had at least one antibiotic prescription were included. Patients with antibiotic prescription were categorized into the three groups of the WHO AWaRe classification — Access, Watch, and Reserve. To assess temporal trends in the AWaRe classification, we performed a multinomial logistic regression analysis adjusted for sex, age, year and Local Health Services. We recorded more than 148 million antibiotic prescriptions. The total annual prescriptions slightly decreased during the study period and the classes most prescribed were combinations of penicillins (28.5%), macrolides (19.3%) and fluoroquinolones (17.4%).Watch antibiotics accounted for 56.5% of all prescriptions, and Access for 43.5%. An increasing of the proportion of Access prescriptions and a corresponding reduction in the prescription of a Watch antibiotic was observed over time (p < 0.0001). Watch prescriptions varied slightly across local health services, from 54% to 61% of the total prescriptions. Watch antibiotics were prescribed more frequently with increasing age: 41.0% in children, 55.7% in adults, 65.8% in older adults and 71.8% in oldest old. Levels of Access antibiotics remained well below the WHO threshold (60%). Prescribing patterns were largely homogeneous across local health services and appeared to be influenced more by local prescribing practices than by overall antibiotic consumption. Older adults and oldest old were largely exposed to Watch antibiotics, underscoring the need for targeted antimicrobial stewardship strategies in this population. Continued surveillance using the WHO AWaRe framework, monitoring and trend analysis of antibiotic prescriptions may reinforce the optimization and appropriateness of community antibiotic prescribing. Furthermore, it can support clinicians and healthcare policymakers in implementing guidelines aimed at limiting the emergence and spread of antimicrobial resistance.Keywords: Antibiotic use, AWaRe classification, Antimicrobial stewardship strategies, Older adults, Healthcare databaseSubject terms: Diseases, Health care, Medical research Introduction Antimicrobial resistance is a growing global issue and represents a significant threat to public health, due to the rapid growth of infections resistant to medications, in particular antibiotics1–3. In 2019, globally, antimicrobial resistance caused more than 1 million deaths1. Moreover, in Europe, estimates based on European Antimicrobial Resistance Surveillance Network data from 2020 indicate that each year more than 35 000 people die as a direct consequence of antimicrobial-resistant infections, with Italy being the country with more deaths – around 12,000 per year-4. To fight it, many countries, Italy included, have implemented guidelines aimed at promoting the rational use of antibiotics5,6. In 2017, the World Health Organization (WHO) introduced the AWaRe classification system for antibiotics, which categorizes antibiotics into three groups—Access, Watch, and Reserve—based on their impact on both clinical practice and potential risk of antimicrobial resistance7. The goal of WHO recommendations is to ensure that 60% of total antibiotic prescription consist of Access group antibiotics, which are characterised by narrow spectrum of activity, typically leading to fewer side effects, a reduced likelihood of antimicrobial resistance selection, and reduced costs. Watch antibiotics carry a higher risk of promoting antimicrobial resistance and should be reserved for patients with more severe conditions. Lastly, Reserve antibiotics are primarily intended for hospital use and should only be prescribed for severe infections caused by multidrug-resistant pathogens. Additionally, the European Centre for Disease Prevention and Control (ECDC) set five targets to be achieved by 2030 in the EU related to the prevention and reduction of antimicrobial resistance, one of which is ensuring that at least 65% of total antibiotic consumption in humans is from the ‘Access’ group, as per WHO’s AWaRe classification8. Only a few studies have evaluated the types of antibiotics prescribed in the community setting according to the WHO AWaRe classification. One Italian study found that the proportion of antibiotics from the Access group correlated closely with overall regional antibiotic consumption, indicating that regions with higher antibiotic use tend to show poorer prescribing patterns and a greater potential impact on bacterial resistance. Antibiotics belonging to the Access group represented 53.6% of total national consumption in the community setting, with regional variability ranging from 47.4% to 62.9%. Only three Region out of twenty-one reached the goal in 2021 of 60% of total antibiotic prescriptions being Access antibiotics9. Pharmacoepidemiological studies are commonly employed to identify variations in medication use, with the aim of informing strategies to optimize prescribing practices. The objective of the present study was to examine trends in antibiotic use in the Lombardy Region between 2000 and 2024, and to assess the prevalence and patterns of use according to the WHO AWaRe classification. Methods Data source and study design This retrospective cohort study was based on healthcare utilization databases from the Lombardy Region, Italy, which has approximately 10 million inhabitants, representing about 15% of the Italian population. These databases include information on hospital admissions to public or private facilities, reimbursable drugs dispensed by regional pharmacies or administered directly within healthcare services, disease-specific exemptions, and demographic data for all residents covered by the Italian National Health Service (NHS)10,11. The pharmacy prescription database contains information on medication names, Anatomical Therapeutic Chemical (ATC) classification codes, quantities dispensed, and dates of dispensation. To retrieve data for our analysis, we performed a record linkage of these healthcare utilization databases, through a unique anonymous subject identification code, in accordance with the Italian privacy regulations. All these databases are linked anonymously with the demographic data using unique encrypted patient codes, in accordance with Italian laws for the treatment of confidential data. By virtue of a specific agreement between the Mario Negri Institute and the Lombardy Region, it was not necessary to obtain approval from any ethics committee for the use of the anonymous administrative data extracted from the healthcare utilization regional databases. All methods were carried out in accordance with relevant guidelines and regulations. Study population Lombardy Region is divided into 8 LHS: Milano, Insubria, Montagna, Brianza, Bergamo, Brescia, Val Padana and Pavia. The database collects information regarding all medication dispensed in the Region, both for people who live in Lombardy and for those who live outside the region (like tourists, visitors or students). We included in the study all residents of the Lombardy Region between January 2000 and December 2024 who had at least one antibiotic prescription during the year, in particular we considered only residents with community setting prescriptions. Patients without available information on their LHS (e.g. tourists or students from other Regions) were excluded from the analysis, to focus our analysis on potential differences in prescribing patterns across regional LHSs. Statistical analysis Continuous variables were summarized as means and standard deviations, while categorical variables were expressed as counts and percentages. Patients receiving antibiotic prescription were first categorized according to the type of antibiotic prescribed, using the fourth level of the ATC classification. Subsequently they were categorized into three groups according to the WHO AWaRe classification — Access, Watch, and Reserve. Temporal trends in antibiotic prescription were analyzed at the fourth levels of the ATC classification. Differences across years by ATC class were assessed using the Chi-square test to evaluate both the overall distribution of ATC classes over time and the yearly distribution within each class. Variability in the prevalence of antibiotic prescriptions across the 8 Local Health Services (LHSs) was evaluated using the Chi-square test for independence. Differences in the proportion of prescriptions across AWaRe groups among LHSs were illustrated using regional maps. LHSs were stratified into quartiles for each AWaRe category, with darker colors indicating higher prescription frequencies. Subjects were divided into four classes, based on the age: children (0–14 years); adults (15–64 years); older adults (65–79 years) and oldest old (≥ 80 years). To assess temporal trends in the AWaRe classification, we performed a multinomial logistic regression analysis adjusted for sex, age, year and LHS. If a patient received antibiotics from multiple AWaRe categories, they were assigned to the most restrictive category (Watch or Reserve). The year included in the model corresponded to the year of prescription, grouped in five period: 2000–2004; 2005–2009; 2010–2014; 2015–2019; 2020–2024. The reference categories were ‘Access’ for the AWaRe classification, ‘Male’ for sex, ‘Milano’ for LHS and 2000–2004 for the year. Statistical significance was set at an alpha level of 0.05, and confidence intervals were calculated using Wald’s method. Results General antibiotic prescription After excluding 1.8 million prescriptions, a total of 148,542,469 antibiotic prescriptions were recorded in the community setting of the Lombardy Region between 2000 and 2024. Prescription for females were slightly more than males, 51.4% vs. 48.6%, and the mean age of individuals who were prescribed antibiotics was 44.3 years old (SD 25.1). Adults (15–64 years old) were accountable for around half of the total prescriptions (51%), while 21% were older adults, around 19% were children (< 14 years old) and 9% oldest old (≥ 80 years old). The inhabitants of Lombardy Region were almost 9 million in 2000 (8,955,839) and from 2012 exceeded the 10 million (10,143,212 in 2024). From 2000 to 2019 the subjects who received at least one prescription of antibiotics remained stable around 33% (32–35%) of the inhabitants of the region. A marked decrease in subjects receiving antibiotic prescriptions was observed in 2020 (24%) and 2021 (22%), likely reflecting the impact of the COVID-19 pandemic (p < 0.0001). After that, the percentage of residents with antibiotic prescription increased again to 27% in 2022 and 29% in 2023 and 2024 (Fig. 1). Percentage of residents with at least one antibiotic prescription per year. The classes of antibiotics, according to WHO-ATC classification, with most prescriptions during the study period were combinations of penicillins (28.5% of total prescriptions), like amoxicillin/clavulanic acid; macrolides (19.3%), like azithromycin; fluoroquinolones (17.4%), like levofloxacin; and penicillins with extended spectrum (11.8%), like amoxicillin. From 2000 to 2024, marked variations emerged when analysing individual antibiotic classes. For example, prescriptions for combinations of penicillins progressively increased from 15.7% to 36.6% of all antibiotic prescriptions (p < 0.0001). Third-generation cephalosporins also showed a significant rise, increasing from 9.7% to 15.0% (p < 0.0001). In contrast, the prescriptions of penicillins with an extended spectrum declined steadily, from 17.0% to 6.5% (p < 0.0001). Fluoroquinolones prescriptions remained stable between 2000 and 2018 (approximately 15–19%), followed by a notable decline from 2018 onward, reaching 10% of total prescriptions in 2024 (Fig. 2). Percentage of the total antibiotic prescriptions divided for classes. Prescription according to AWaRe classification According to the AWaRe classification, Watch antibiotics accounted for 56.5% of all prescriptions, whereas Access antibiotics represented 43.5%. Reserve antibiotics were rarely used (< 0.1%). Over the 2000–2024 period, the proportion of Watch prescriptions declined from 62.9% (in 2000) to 52.0% (in 2024), while Access prescriptions increased from 37.1% to 48.0% (p < 0.0001) (see Fig. 3). Antibiotic prescription according to AWaRe classification. Age-stratified analyses showed that Access antibiotics were more frequently prescribed than Watch antibiotics among children (59.0% vs. 41.0%). In contrast, Watch antibiotics were more prescribed in adults (55.7%), older adults (65.8%) and oldest old (71.8%), as reported in Table 1. Table 1Total antibiotic prescriptions divided according to AWaRe classification.AccessWatchReservep-valueTotal64,548,194 (43.5)83,990,109 (56.5)4,166 (< 0.1)Age group Children16,566,166 (59.0)11,498,912 (41.0)73 (< 0.1)< 0.0001 Adults33,498,594 (44.3)42,164,144 (55.7)2,024 (< 0.1)< 0.0001 Older adults10,540,779 (34.2)20,296,624 (65.8)1,371 (< 0.1)< 0.0001 Oldest old3,942,655 (28.2)10,030,429 (71.8)698 (< 0.1)< 0.0001LHS Milano20,800,871 (44.2)26,290,550 (55.8)1,586 (< 0.1)< 0.0001 Insubria8,806,269 (41.2)12,581,691 (58.8)728 (< 0.1)< 0.0001 Montagna1,814,539 (42.6)2,446,858 (57.4)65 (< 0.1)< 0.0001 Brianza8,343,079 (43.7)10,752,044 (56.3)433 (< 0.1)< 0.0001 Bergamo7,363,448 (44.7)9,129,156 (55.4)463 (< 0.1)< 0.0001 Brescia9,276,357 (45.5)11,103,809 (54.5)427 (< 0.1)< 0.0001 Val Padana4,994,487 (42.7)6,713,811 (57.3)240 (< 0.1)< 0.0001 Pavia3,149,144 (38.8)4,972,190 (61.2)224 (< 0.1)< 0.0001 p-value< 0.0001< 0.0001< 0.0001 Total antibiotic prescriptions divided according to AWaRe classification. Macrolides (e.g. azithromycin, clarithromycin) were the most prescribed antibiotics in the Watch group, followed by fluoroquinolones (e.g. levofloxacin). In the Access group, the most prescribed antibiotic classes were combinations of penicillins (e.g. amoxicillin/clavulanic acid) and penicillins with extended spectrum (e.g. amoxicillin). The specific drugs, or their combination, with more prescriptions over the years in the Access group were amoxicillin/clavulanic acid (65.2% of Access prescriptions), amoxicillin (25.9%), and sulfamethoxazole/trimethoprim (4.0%). The ones with more prescriptions in the Watch group were azithromycin (15.8% of the Watch prescriptions), clarithromycin (14.7%) and levofloxacin (13.3%). Female patients had a higher likelihood of receiving a Watch rather than an Access antibiotic (OR 1.11, p < 0.0001). Increasing age was also associated with a small but statistically significant higher probability of being prescribed a Watch antibiotic compared with an Access antibiotic (OR 1.01, p < 0.0001) (see Table 2). Table 2Logistic model.Reference access antibioticWatchReservep-valueFemale vs. Male1.18 (1.17–1.18)0.72 (0.67–0.78)< 0.0001Age1.01 (1.01–1.01)1.05 (1.05–1.05)< 0.0001Time (reference 2000–2004) 2005–20090.80 (0.79–0.80)0.25 (0.23–0.28)< 0.0001 2010–20140.78 (0.77–0.78)0.07 (0.06–0.09)< 0.0001 2015–20190.75 (0.75–0.75)0.02 (0.02–0.03)< 0.0001 2020–20240.68 (0.68–0.68)0.02 (0.01–0.02)< 0.0001 Logistic model. Over the 24-year study period, prescriptions of Watch antibiotics progressively decreased, with a corresponding reduction in the probability of receiving a Watch antibiotic over time. In the last five years of observation (2020–2024), the odds of being prescribed a Watch antibiotic rather than an Access antibiotic were 32% lower compared with the first five years of the study period (2000–2004), with an odds ratio (OR) of 0.68 (95% CI 0.68–0.68, p < 0.0001) (see Table 2). Variability between LHS LHS of Milan (Metropolitan city), the LHS with most inhabitants, was the one with more prescriptions from 2000 to 2024 with more than 47 million of total antibiotic prescriptions. It was followed by LHS Insubria (21 million of prescriptions), Brescia (20 million of prescriptions) and Monza-Brianza (19 million of prescriptions). Percentage of residents taking at least one prescription annually varied between LHS from 31.0% of Milan LHS to 36.7% of Brescia LHS. For all LHS the percentage of residents taking at least one antibiotic annually was stable from 2000 (ranging from 32% to 40%) to 2019 (ranging from 30% to 35%), then decrease during COVID-19 pandemic (from 21% to 25%) and then started to rise again reaching percentage of residents taking at least one antibiotic from 28% (Milano) to 33% (Brescia) in 2024 (p < 0.0001, see Fig. 4). Percentage of residents taking at least one antibiotic per year, according to LHS of residence. Percentage of Watch antibiotics prescriptions varied slightly across LHS, from 54% to 61% (p < 0.0001) of the total prescriptions (see Table 1). Figure 5 illustrates the distribution of antibiotic prescriptions across Local Health Services for the Access (green), Watch (yellow), and Reserve (red) groups. Darker colours indicate a higher frequency of prescriptions. Regional map indicating division of Local Health Services (a). Panels show frequency of (b) Access prescriptions, (c) Watch prescriptions and (d) Reserve prescriptions and LHS are stratified in four quartiles where darker colours mean higher frequency. Inhabitants of Pavia LHS had 23% more probability of being prescribed a Watch antibiotic rather than an Access compared to LHS of Milan (OR 1.23, 95% CI 1.23–1.23, p < 0.0001). Similar, inhabitants of Insubria LHS had 14% more probability of being prescribed a Watch antibiotic than an Access compared to LHS of Milan (OR 1.14, 95% CI 1.14–1.15, p < 0.0001). Discussion Our study found that penicillins, particularly combinations of penicillins (such as amoxicillin/clavulanic acid), were the most frequently prescribed antibiotic class over a long, 24-years, observation period in the most populous Italian regions (around 10 million people in 2024) and their prescriptions increased during the years, reaching more than one third of total prescriptions in 2024 (37%). At the end of the study period, the percentage of residents taking at least one antibiotic prescription annually has slightly decrease compared to the beginning of the study (29.6% in 2024 vs. 33.7% in 2000). Adults, older adults and oldest old were prescribed Watch antibiotics more frequently than children. Throughout the study period, Watch antibiotics were prescribed more often than Access or Reserve antibiotics, with small but statistically significant variations across Local Health Services. However, the rate of prescriptions of Access antibiotics increased progressively from 2000 to 2024, likely reflecting a more careful evaluation of the benefit–risk ratio in antibiotic selection. Despite this improvement, the proportion of Access antibiotics, recommended as first-line treatments for many indications, remained below both the WHO and ECDC target (Access group account for at least 60%-65% of total antibiotic prescriptions) throughout the study period. Access antibiotics, started in 2000 as 37% of the total, reached 48% of total prescriptions in 2024. Our results are consistent with those reported by the Italian Medicines Agency (AIFA-Agenzia Italiana del Farmaco) and by Gagliotti et al., even though we used a different criterion evaluating the individual subjects receiving antibiotic treatment rather than the defined daily doses (DDDs) per 1,000 inhabitants per day, we highlighted a suboptimal use of Access antibiotic in Lombardy region. Report by AIFA found that Access antibiotics accounted for 54.4% of total prescriptions nationwide12, as well as with a 2021 Italian study conducted in the community setting showing that Access antibiotic use were suboptimal, representing the 53.6% of total prescriptions9. In comparison, in the European Union the average of Access antibiotics prescriptions was 60.7% of the total, but only nine EU Member States have met or exceeded the target of 65% antibiotic consumption being from the Access group8,13. Previous studies have highlighted a strong inverse correlation between overall antibiotic consumption and the proportion of Access antibiotics across Italian regions: higher levels of antibiotic use were associated with lower percentages of Access agents and a greater reliance on antibiotics with higher resistance potential9. In contrast, in our analysis we observed substantial homogeneity between Local Health Services in the classes of antibiotics prescribed. Notably, the use of Watch antibiotics did not appear to be associated with the total volume of antibiotic consumption, suggesting that local prescribing behaviors may play a greater role than overall consumption levels in patterns of Watch antibiotic use. According to AIFA, individuals aged 65 years and older account for a high proportion of antibiotic users, approximately half of all users in 202312. Our study found that 30% of the total prescriptions were for older adults and oldest old, less than the percentage reported from AIFA, and that they had more prescriptions of Watch group than adults and children, with two-thirds of their prescription being Watch group antibiotics, probably reflecting more complicated infections or severe clinical situations. This data is slightly better, but still consistent with the results of a study conducted in a network of Italian internal medicine and geriatric wards, where older adults had 81% of the prescriptions belonging to Watch group14. One positive finding of our study is the consistent reduction in prescriptions of Watch antibiotics over time. This decline was partly driven by the marked decrease in fluoroquinolone use observed from 2019 onward, reflecting the impact of European Medicines Agency (EMA) regulatory restrictions issued in response to reports of rare but severe adverse events, particularly among older adults15. However, this trend may also due to improved prescribing appropriateness, supported by the implementation of national action plans aimed at combating antimicrobial resistance5. Indeed, the adoption of coordinated national strategies has been consistently associated with favourable trends across multiple indicators, including antibiotic consumption, absolute rates of antimicrobial resistance, and the burden of antibiotic-resistant infections in humans16. We highlighted a low use of Access group antibiotics among adults over 65 years old in the community setting. This finding is consistent with the type and severity of infections typically observed in older adults compared with younger populations, as well as with the higher prevalence of antimicrobial resistance in this age group17,18. Indeed, broad-spectrum agents are more frequently prescribed with increasing of age because adults over 65 and even more those over 80 years of age are more often present with severe, atypical, or complicated infections, which may require empirical treatments with a wider antibacterial spectrum. Moreover, for the most common infections (particularly pneumonia) the increasing burden of antimicrobial resistance may lead to a higher proportion of patients who do not respond to Access group antibiotics, which are recommended as first-line treatments, thereby requiring the use of broader-spectrum agents (Watch group) or combinations of antibiotics. For instance, in community-acquired pneumonia, even in severe cases, Access antibiotics such as ampicillin or amoxicillin–clavulanate remain appropriate as first–line options and should be used, instead of Watch antibiotics, in the majority of the not-complicated cases. Importantly, Watch antibiotics are prescribed for a wide variety of indications worldwide, including both therapeutic and prophylactic purposes, highlighting the need for more stringent and harmonized prescribing practices19. A possible explanation of the high use of Watch antibiotics found in our study is that for the most common infections, the rise of antimicrobial resistance can lead to an increase of patients not responsive to treatments from the Access groups - first line treatment -, needing more broad-spectrum antibiotics (like third-generation cephalosporin) or more than one antibiotic treatment simultaneously (like combination of penicillin), as we observed in a similar study conducted in a large sample of Italian internal medicine wards14. For this purpose, AWaRe classification system is helpful to guide health practitioners to the most appropriate antibiotic prescription and to reduce resistance7. Development and implementation of local guidelines aligned with this classification and national recommendations can help ensure that Watch antibiotics are reserved as second- or third-line options, while Access antibiotics used as first-line choices if appropriate. Similarly, formulary restrictions or prescriber approval systems (for example, requiring infectious diseases specialist sign-off) can further limit inappropriate Watch antibiotic use. Recently, in support of national antimicrobial stewardship objectives, in the UK an adapted AWaRe list has been developed through a consensus-reaching procedure. This list is intended to facilitate antibiotic usage goals set within the UK Antimicrobial Resistance 2024–2029 National Action Plan20. The lack of information on local antimicrobial resistance patterns, type of infections and antibiogram results limited our ability to more accurately assess the appropriateness of antibiotic prescriptions. Nevertheless, to our knowledge, this is the first study to investigate the prevalence and temporal trends of antibiotic use according to the WHO AWaRe classification in the most populous Italian region over a 24-year period. A strength of this study is the use of a large administrative database from Lombardy where the information is readily available, collected in a standardized way, and inexpensive to use, allowing for a comprehensive analysis of real-world big data. This long-term observation provides a valuable opportunity to characterize prescribing patterns and evaluate changes in antibiotic use over time at a population level. Conclusion Over a 24-year period, outpatient antibiotic prescribing in the most populous Italian region showed a modest reduction in overall exposure and a gradual increase in the use of Access antibiotics, although levels remained well below the threshold recommended by the WHO. Watch antibiotics continued to be prescribed more frequently than Access agents, and the targets set by the WHO and the ECDC for Access antibiotic use were not achieved. Prescribing patterns were largely homogeneous across Local Health Services and appeared to be influenced more by local prescribing practices than by overall antibiotic consumption. Older adults and oldest old were largely exposed to Watch antibiotics, underscoring the need for targeted antimicrobial stewardship strategies in this population. Continued surveillance using the WHO AWaRe framework, monitoring and trend analysis of antibiotic prescriptions may reinforce the optimization and appropriateness of community antibiotic prescribing. Furthermore, it can support clinicians and healthcare policymakers in implementing guidelines aimed at limiting the emergence and spread of antimicrobial resistance. Acknowledgements We thank Giuseppe Preziosi, Monica Arivetti, and Giovanna Rigotti from ARIA S.p.A, Alfredo Bevilacqua from Laife Reply S.p.A., Marco D. Forlani from T Bridge–BV Tech S.p.A, and Igor Monti from Mario Negri Institute for Pharmacologic Research IRCCS who kindly assisted us with data collection. Abbreviations World Health Organization European Centre for Disease Prevention and Control National health service Anatomical therapeutic chemical Local health service Agenzia Italiana del Farmaco (Italian Medicines Agency) European Medicines Agency Author contributions C.E. and L. P. designed the study, interpreted the data and wrote the manuscript. C.C. analysed the data, interpreted the data and contributed to write the manuscript. A.N. and I. F. provided critical revisions. All authors approved the final version. Funding This study was supported by grants from the Health Ministry of the Lombardy region as part of the EPIFARM-Pharmaco-epidemiology Agreement between the Istituto di Ricerche Farmacologiche Mario Negri IRCCS and the Lombardy region (DGR XII/1730–15/01/2024 within the “EPIFARM-Pharmaco-Epidemiology” project). Data availability The data that support the findings of this study are available from Lombardy Region but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. The data are not publicly available due to privacy restrictions. The data that support the findings of this study are available from the corresponding author (Elli Chiara), upon reasonable request and with approval of Lombardy Region. Declarations Competing interests The authors declare no competing interests. Ethics approval The source of data was the administrative database of the Lombardy Region, which stores all community-dwelling prescriptions covered by the National Health Service (NHS) according to the Italian national formulary, and issued to individuals living in the Lombardy Region. Each prescription record contains information on the drug dispensed, the prescriber, the dispensing pharmacy and patient data, such as unique personal identifier code, sex, date of birth, and local health unit code. Ethical approval was not necessarily due to the nature of the data (secondary data analysis of anonymized data). The study was based on administrative database and the participants were not identifiable to the authors. According to the Italian law, studies using anonymous data from administrative databases that do not involve direct access to individual patient data need no approval from or notification by an ethics committee/institutional review board, and informed patient consent is not required. All data were managed according to Italian law on privacy. Written informed consent to participate in this study was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and the institutional requirements. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The data that support the findings of this study are available from Lombardy Region but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. The data are not publicly available due to privacy restrictions. The data that support the findings of this study are available from the corresponding author (Elli Chiara), upon reasonable request and with approval of Lombardy Region.